These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 34758170)

  • 1. IFN-γ-induced PD-L1 expression on human melanocytes is impaired in vitiligo.
    Willemsen M; Krebbers G; Tjin EPM; Willemsen KJ; Louis A; Konijn VAL; Narayan VS; Post NF; Bakker WJ; Melief CJM; Bekkenk MW; Luiten RM
    Exp Dermatol; 2022 Apr; 31(4):556-566. PubMed ID: 34758170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the PD-1/PD-L1 Axis in Human Vitiligo.
    Willemsen M; Melief CJM; Bekkenk MW; Luiten RM
    Front Immunol; 2020; 11():579022. PubMed ID: 33240267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
    Qian J; Wang C; Wang B; Yang J; Wang Y; Luo F; Xu J; Zhao C; Liu R; Chu Y
    J Neuroinflammation; 2018 Oct; 15(1):290. PubMed ID: 30333036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of T-cell-mediated immune response via the PD-1/ PD-L1 axis in cholangiocarcinoma cells.
    Suriyo T; Fuangthong M; Artpradit C; Ungtrakul T; Sricharunrat T; Taha F; Satayavivad J
    Eur J Pharmacol; 2021 Apr; 897():173960. PubMed ID: 33617828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the elevated IFN-γ in vitiligo patients by human anti- IFN-γ monoclonal antibody hampers direct cytotoxicity in melanocyte.
    Ng CY; Chan YP; Chiu YC; Shih HP; Lin YN; Chung PH; Huang JY; Chen HK; Chung WH; Ku CL
    J Dermatol Sci; 2023 Jun; 110(3):78-88. PubMed ID: 37221109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas-FasL interaction in cytotoxic T cell-mediated vitiligo: The role of lesional expression of tumor necrosis factor-α and interferon-γ in Fas-mediated melanocyte apoptosis.
    Jimbo H; Nagai H; Fujiwara S; Shimoura N; Nishigori C
    Exp Dermatol; 2020 Jan; 29(1):61-70. PubMed ID: 31675451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PD-1 with PD-L1 Axis Is Pertinent with the Immune Modulation of Atrial Fibrillation by Regulating T Cell Excitation and Promoting the Secretion of Inflammatory Factors.
    Chang G; Chen Y; Liu Z; Wang Y; Ge W; Kang Y; Guo S
    J Immunol Res; 2022; 2022():3647817. PubMed ID: 35600045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type I interferon signaling limits viral vector priming of CD8
    Riding RL; Richmond JM; Fukuda K; Harris JE
    Pigment Cell Melanoma Res; 2021 Jul; 34(4):683-695. PubMed ID: 33040466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed Death Ligand 1 Indicates Pre-Existing Adaptive Immune Response by Tumor-Infiltrating CD8
    Li YM; Yu JM; Liu ZY; Yang HJ; Tang J; Chen ZN
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31627272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glial cells suppress postencephalitic CD8+ T lymphocytes through PD-L1.
    Schachtele SJ; Hu S; Sheng WS; Mutnal MB; Lokensgard JR
    Glia; 2014 Oct; 62(10):1582-94. PubMed ID: 24890099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells.
    Homma S; Hayashi K; Yoshida K; Sagawa Y; Kamata Y; Ito M
    Int Immunopharmacol; 2018 Jan; 54():39-45. PubMed ID: 29100036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytomegalovirus UL23 exploits PD-L1 inhibitory signaling pathway to evade T cell-mediated cytotoxicity.
    Yuan Q; Fan Z; Huang W; Huo X; Yang X; Ran Y; Chen J; Li H
    mBio; 2024 Jul; 15(7):e0119124. PubMed ID: 38829126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.
    van den Boorn JG; Konijnenberg D; Dellemijn TA; van der Veen JP; Bos JD; Melief CJ; Vyth-Dreese FA; Luiten RM
    J Invest Dermatol; 2009 Sep; 129(9):2220-32. PubMed ID: 19242513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasopharyngeal cancer cell-derived exosomal PD-L1 inhibits CD8+ T-cell activity and promotes immune escape.
    Yang J; Chen J; Liang H; Yu Y
    Cancer Sci; 2022 Sep; 113(9):3044-3054. PubMed ID: 35598173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-γ treatment protocol for MHC-I
    Stifter K; Krieger J; Ruths L; Gout J; Mulaw M; Lechel A; Kleger A; Seufferlein T; Wagner M; Schirmbeck R
    J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32868392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo.
    Boukhedouni N; Martins C; Darrigade AS; Drullion C; Rambert J; Barrault C; Garnier J; Jacquemin C; Thiolat D; Lucchese F; Morel F; Ezzedine K; Taieb A; Bernard FX; Seneschal J; Boniface K
    JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32369451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo.
    Wańkowicz-Kalińska A; van den Wijngaard RM; Tigges BJ; Westerhof W; Ogg GS; Cerundolo V; Storkus WJ; Das PK
    Lab Invest; 2003 May; 83(5):683-95. PubMed ID: 12746478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8+ T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis.
    Wu J; Zhou M; Wan Y; Xu A
    Mol Med Rep; 2013 Jan; 7(1):237-41. PubMed ID: 23042234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma Inhibits Melanogenesis and Induces Apoptosis in Melanocytes: A Pivotal Role of CD8+ Cytotoxic T Lymphocytes in Vitiligo.
    Yang L; Wei Y; Sun Y; Shi W; Yang J; Zhu L; Li M
    Acta Derm Venereol; 2015 Jul; 95(6):664-70. PubMed ID: 25721262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking of programmed cell death-ligand 1 (PD-L1) expressed on endothelial cells promoted the recruitment of CD8
    Li Q; Wei S; Li Y; Wu F; Qin X; Li Z; Li J; Chen C
    Inflamm Res; 2023 Apr; 72(4):783-796. PubMed ID: 36867228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.